Psoriasis Research Review, Issue 55

In this issue:

Atrial fibrillation or CV risk with ustekinumab vs TNF inhibitors
Herpes zoster in psoriasis or psoriatic arthritis
Secukinumab and ixekizumab drug survival in plaque psoriasis
Methotrexate effects on T-cell subsets
Psoriasis symptom inventory in clinical care
Tildrakizumab for moderate-to-severe plaque psoriasis
Calcipotriol + betamethasone dipropionate aerosol foam for plaque psoriasis
Rapid action of calcipotriol/ betamethasone dipropionate foam
PGA scale to assess psoriasis disease severity
Treatment of moderate-to-severe psoriasis in HIV patients
Adalimumab after anti-TNF-α failure in plaque-type psoriasis

Please login below to download this issue (PDF)

Subscribe